BIOREGENX, INC. (BRGX) stock: key figures, P/E, revenue and dividend
Information Technology · United States
BIOREGENX, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.85 m USD |
| Gross profit | 1.50 m USD |
| Operating income | -1.24 m USD |
| EBIT | -1.24 m USD |
| Net income | -1.54 m USD |
| Diluted EPS – continuing operations | 0.00 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BIOREGENX, INC.
BioRegenx, Inc. engages in the research, development, and commercialization of dietary supplements, medical devices, software, and contactless diagnostic technologies in the United States and internationally. The company offers DocSun AI engine, which integrates with a ballistocardiograph that detects an individual's heartbeat; TruScan.AI mobile app for additional health indications; VitalWellness app for DNA and epigenetics platform; and Endocalyx Pro, a dietary supplement targeting microvascular capillary health. It also provides MyBodyRx, a supplement; GlycoCheck software and medical devices; hydrogen water products and health and wellness devices, such as pulsed electro-magnetic field devices; StimaWELL and ReLounge electronic muscle stimulation therapy devices; and Findit.com, a social media content management platform. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.
More stocks
- Cenntro Inc. (CENN)
- CIRTRAN CORP (CIRX)
- Transglobal Management Group, Inc. (TMGI)
- Leopard Energy, Inc. (LEEN)
- Zoomcar Holdings, Inc. (ZCAR)
- Emo Capital Corp. (NUVI)
- Rainmaker Worldwide Inc. (RAKR)
- SPLASH BEVERAGE GROUP, INC. (EDVA)
- Bubblr Inc. (BBLR)
- 3DX Industries, Inc. (DDDX)
- Electromedical Technologies, Inc (EMED)
- PINEAPPLE EXPRESS CANNABIS Co (PNXP)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.